These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32401759

  • 1. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA, Joffe LS, Alves GM, Figueiredo-Carvalho MHG, Brito-Santos F, Amaral ACF, Rodrigues ML, Almeida-Paes R.
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S, Lei W, de Hoog GS, Yang L, Vitale RG, Rafati H, Seyedmousavi M, Tolooe A, van der Lee H, Liao W, Verweij PE, Seyedmousavi S.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS, de Almeida AMZ, Basano SA, Takagi EH, Szeszs MW, Melhem MSC, Albuquerque M, Camargo JSAA, Gambale W, Camargo LMA.
    Med Mycol; 2020 Feb 01; 58(2):172-180. PubMed ID: 31329924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, De Hoog GS, Meis JF.
    Antimicrob Agents Chemother; 2010 Apr 01; 54(4):1636-8. PubMed ID: 20086140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, Xi L.
    Med Mycol; 2012 Aug 01; 50(6):649-53. PubMed ID: 22309458
    [Abstract] [Full Text] [Related]

  • 15. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
    Deng S, de Hoog GS, Badali H, Yang L, Najafzadeh MJ, Pan B, Curfs-Breuker I, Meis JF, Liao W.
    Antimicrob Agents Chemother; 2013 Apr 01; 57(4):1974-7. PubMed ID: 23380718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A case of chromoblastomycosis with an unusual clinical manifestation caused by Phialophora verrucosa on an unexposed area: treatment with a combination of amphotericin B and 5-flucytosine.
    Park SG, Oh SH, Suh SB, Lee KH, Chung KY.
    Br J Dermatol; 2005 Mar 01; 152(3):560-4. PubMed ID: 15787829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
    Calvo E, Pastor FJ, Salas V, Mayayo E, Capilla J, Guarro J.
    J Antimicrob Chemother; 2012 Mar 01; 67(3):666-70. PubMed ID: 22190608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.